TY - JOUR
T1 - Pacientes con infección por VIH/SIDA en una Unidad de Pacientes Críticos. La experiencia de un hospital general en un país en desarrollo
AU - Verdugo, Fernando
AU - Pinto, Francisco
AU - Charpentier, Paulo
AU - Von Mühlenbrock, Christian
AU - Soto, Andrés
AU - Dabanch, Jeannette
AU - Cubillos, Alberto Fica
N1 - Publisher Copyright:
© 2015, Rev Chilena Infectol. All right reserved.
PY - 2015/8/4
Y1 - 2015/8/4
N2 - Introduction and aims: Despite general availability of HAART in Chile, admissions of HIV/AIDS patients to Intensive-Intermediate Care Units (IICU) are still happening, and a characterization of patient´s profile, mortality and potentially avoidable admissions is necessary. Methods: Observational retrospective study in one general hospital in Chile of HIV/AIDS patients admitted to IICU during 9 years. Results: During 2005-2013, 32 patients were admitted to IICU, with 87.5% in AIDS stage, only 53.1% knew his/her condition, 43,8% were receiving HAART and 16.6% chemoprophylaxis for opportunistic infections. A CD4 count < 200/μL was registered in 75.9% of patients. Most admissions were driven by infectious conditions (84.4%) and 48.1% developed septic shock. IICU hospitalizations were motivated by respiratory failure, neurologic compromise, sepsis or a mixture of them (87.5%). By univariate analysis, admissions by respiratory failure were associated to no HAART, oral candidiasis or CD4 < 250/μL (p < 0.01). Eight patients died during their first hospitalization (25%) and other 5 in the following month after discharge. Death during hospitalization was significantly associated to vasoactive drug use ≥ 7 days (OR 16.5; IC95 2.1-128 p < 0.01). In multivariate analysis, APACHE score ≥ 18 was associated with death during hospitalization of after discharge (OR 3.3 IC95 1.1-10; p < 0.05). Four patients (12.5%) had potentially avoidable admissions. Conclusions: Despite HAART availability in Chile, hospitalizations of patients with HIV/AIDS are still happening, affecting those that either are unaware of his/her condition, are not receiving HAART and/or chemoprophylaxis. These admissions generate premature deaths and happen even after discharge in severely ill patients.
AB - Introduction and aims: Despite general availability of HAART in Chile, admissions of HIV/AIDS patients to Intensive-Intermediate Care Units (IICU) are still happening, and a characterization of patient´s profile, mortality and potentially avoidable admissions is necessary. Methods: Observational retrospective study in one general hospital in Chile of HIV/AIDS patients admitted to IICU during 9 years. Results: During 2005-2013, 32 patients were admitted to IICU, with 87.5% in AIDS stage, only 53.1% knew his/her condition, 43,8% were receiving HAART and 16.6% chemoprophylaxis for opportunistic infections. A CD4 count < 200/μL was registered in 75.9% of patients. Most admissions were driven by infectious conditions (84.4%) and 48.1% developed septic shock. IICU hospitalizations were motivated by respiratory failure, neurologic compromise, sepsis or a mixture of them (87.5%). By univariate analysis, admissions by respiratory failure were associated to no HAART, oral candidiasis or CD4 < 250/μL (p < 0.01). Eight patients died during their first hospitalization (25%) and other 5 in the following month after discharge. Death during hospitalization was significantly associated to vasoactive drug use ≥ 7 days (OR 16.5; IC95 2.1-128 p < 0.01). In multivariate analysis, APACHE score ≥ 18 was associated with death during hospitalization of after discharge (OR 3.3 IC95 1.1-10; p < 0.05). Four patients (12.5%) had potentially avoidable admissions. Conclusions: Despite HAART availability in Chile, hospitalizations of patients with HIV/AIDS are still happening, affecting those that either are unaware of his/her condition, are not receiving HAART and/or chemoprophylaxis. These admissions generate premature deaths and happen even after discharge in severely ill patients.
KW - Acquired immunodeficiency syndrome
KW - Adult
KW - HIV
KW - Highly active antiretroviral therapy
KW - In-hospital mortality
KW - Intensive care
KW - Long term survivors
KW - Respiratory failure
KW - Risk factors
KW - Septic shock
KW - Severe sepsis
UR - https://www.scopus.com/pages/publications/84938546267
U2 - 10.4067/s0716-10182015000400007
DO - 10.4067/s0716-10182015000400007
M3 - Article
C2 - 26230436
AN - SCOPUS:84938546267
SN - 0716-1018
VL - 32
SP - 294
EP - 303
JO - Revista Chilena de Infectologia
JF - Revista Chilena de Infectologia
IS - 3
ER -